Articles Service
Research article
Crystal Structures of 6-Phosphogluconate Dehydrogenase from Corynebacterium glutamicum
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea
2KNU Institute for Microorganisms, Kyungpook National University, Daegu 41566, Republic of Korea
J. Microbiol. Biotechnol. 2023; 33(10): 1361-1369
Published October 28, 2023 https://doi.org/10.4014/jmb.2305.05002
Copyright © The Korean Society for Microbiology and Biotechnology.
Abstract
Keywords
Graphical Abstract
Introduction
The PPP, which is the essential pathway in cellular metabolism, provides a precursor for nucleotide or amino acid synthesis and protects cells against oxidative stress. The PPP can be divided into two phases : the oxidative phase (OPPP) and the non-oxidative phase (NOPPP). During the oxidative phase, NADPH is produced from glucose using the reducing power of glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGD). These two isoenzymes play an important role in this pathway in terms of the production of NADPH, which is an essential co-factor to the survival of cells and a biological reducing agent that is used in the synthesis of fatty acids and cholesterol [14]. Moreover, many studies have indicated that NADPH is a key factor in cellular antioxidation systems and oxidative stress [15]. However, cells contain more NAD than NADP. Therefore, a suitable intracellular NADPH level is important for maintaining the redox balance in cells [16]. To reduce this imbalance of energy-carrying molecules in cells, many researchers have attempted to replace NADP-dependent enzyme with NAD-dependent enzyme. For this reason, G6PDH and 6PGD, which can produce NADPH, are important. These enzymes react with NADP, rather than NAD, thus easily offering NADPH in cells.
Furthermore, 6PGD, which catalyzes the conversion of 6-phosphogluconate (6PG) to ribulose 5-phosphate (Ru5P) using NADP in the third step of PPP, to produce NADPH (Fig. 1A) [17], is well known as a drug target in cancer and infection. Studies on the control of 6PGD revealed that this causes a decrease in lipogenesis and RNA biosysnthesis and an increase in ROS levels, consequently hindering the growth of cancer cells [18] . Moreover, 6PGD plays an important role in the metabolic system, but also acts as a potential drug target for African trypanosomes [19, 20]. The structures of the 6PGD-based amino acid sequences from
-
Fig. 1. Reaction and sequence alignment of
Cg 6PGD. (A) Enzymatic reaction of 6-phospho gluconate dehydrogenase. NADPH and CO2 are produced from this reaction. (B) Amino acid sequence alignment ofCg 6PGD with other 6PGD structures. The secondary structural elements are drawn based on the structure ofCg 6PGD and labeled. Residues that were involved in catalytic activity, substate-binding, and NADP-binding are presented using differently colored triangles, respectively.
The present research focused on the 6PGD from
Materials and Methods
Expression and Purification
The
Crystallization
After the purification of the
Each experiment consisted of mixing 1.0 ul of protein solution (41.25 mg ml–1 in 40 mM Tris-HCl, pH 8.0) with 1.0 ml of reservoir solution and equilibrating the drop against 50 ul of reservoir solution. The crystals of
Data Collection and Structure Determination
The best quality
-
Table 1 . Data collection and refinement statistics of
Cg 6PGD apo and complex form.Cg 6PGD_apoCg 6PGD_NADPData collection Space group P 21 21 21 P 21 21 21 Cell dimensions a, b, c (Å)63.90 120.30 152.60 64.00 119.47 153.45 α, β, γ () 90.00 90.00 90.00 90.00, 90.00, 90.00 Resolution (Å) 50.00-2.44 50.00-1.93 R sym orR merge12.1 (36.9) 6.5 (33.8) CC1/2 0.978 (0.773) 0.992 (0.93) I / σ (I) 15.9 (3.18) 35.667 (6.865) Completeness (%) 94.9 (92.4) 99.0 (97.4) Redundancy 3.2 (2.5) 5.5 (5.5) Refinement Resolution (Å) 33.99-2.41 33.84-1.90 No. reflections 41803 87822 R work /R free19.951 / 26.708 16.408 / 20.217 No. atoms 7314 8011 Protein 7238 7218 Ligand/ion 0 143 Water 76 650 B -factors39.794 22.082 Protein 42.582 22.903 Ligand/ion 0 44.127 Water 35.828 30.075 R.m.s. deviations Bond lengths (Å) 0.008 0.011 Bond angles (°) 1.615 1.643 PDB ID 8I4N 8I4Q
Analytical Size-Exclusion Chromatography
To determine the oligomeric status of
Amino Acid Sequence Analysis of Substrate Binding Site
The amino acid sequence analysis was performed using a position-specific iterated basic local alignment search tool (PSI-BLAST). For this, 705
Molecular Docking Simulation
A simulation of the molecular docking of 6PG to the
The grid box size for
Enzymatic Activity Assay
The Enzymatic activity of
Results and Discussion
Overall Structure of Cg 6PGD
We determined that the crystal structures of
-
Fig. 2. Overall structure of
Cg 6PGD. (A) Dimeric structure ofCg 6PGD. The dimeric structure is shown as a cartoon model, and the two chains are distinguished with different colors : green and magenta, respectively. NADP is presented as a gray-colored sphere model. (B) Size-exclusion chromatography ofCg 6PGD. a is a void peak, b is ferritin (440 kDa), c is aldolase (158 kDa), d is ovalbumin (44 kDa) and e is ribonuclease (13.7 kDa).Cg 6PGD is eluted as a dimer. (C) Domain classification ofCg 6PGD using a cartoon model of the monomer. The N-term domain is indicated in blue, the CD is indicated in red, and the Cterm domain is indicated in yellow.
The monomeric structure of
Substrate-Binding Site and Catalytic Residues
The substrate-binding mode was predicted via the alignment of our structure with the
-
Fig. 3. Substrate(6PG)-binding model of
Cg 6PGD. (A) Structure comparison betweenOa 6PGD_apo,Oa 6PGD_6PG andCg 6PGD_apo. All structures are presented as cartoon diagrams. The structures are depicted in gray (Oa 6PGD_apo), purple (Oa 6PGD_6PG) and cyan (Cg 6PGD). (B) Docking simulation ofCg 6PGD with 6PG. Hydrogen bonds between the residues and 6PG are expressed, with the exception of water-meditated hydrogen bonds. 6PG is presented as a magenta-colored stick model, and the substrate-binding residue is presented as a cyan-colored stick model. All residues are labeled. (C) Domains associated with the binding of 6PG. (D) Catalytic residues ofCg 6PGD andOa 6PGD.Cg 6PGD is presented as a cyan-colored cartoon model, andOa 6PGD is presented as a green-colored cartoon model. The catalytic residues are presented using sticks and labeled.
Docking simulations of the substrate were also performed to predict the substrate-binding mode. The 6PG molecule fitted the substrate-binding cavity well, which was predicted based on other similar structure (Fig. 3B). In the substrate-binding pocket, the N-term domain, CD, C-term domain were involved in the binding of substrate. The phosphate of 6PG interacted with Tyr195, Lys260 and Arg287 in the CD; and with Arg446 in the C-term domain of another chain (Figs. 3B and 3C).
The catalytic residues of 6PGD are well known,
NADP-Binding Site
To characterize the conformational change between
-
Fig. 4. Co-factor (NADP)-binding model of
Cg 6PGD. (A) Electrostatic potential surface of theCg 6PGD_apo (left) andCg 6PGD_NADP (right) forms. NADP molecules are shown as gray-colored stick models. (B) Conformational changes inCg 6PGD_NADP. NADP is presented as a sphere model. The difference in loop distance is labeled. (C) Co-factor (NADP)- binding model ofCg 6PGD. The structure ofCg 6PGD is shown as a cartoon diagram, and the residues that bind to NADP are presented as stick models and labeled. (D) Pyrophosphate of the NADP-binding form.
A NADP-binding site was observed in the N-term domain. The NADP-binding site was constructed by Ala16, Met18, Asn37, Arg38, Ser39, Lys42, Val79, Gln80, Asn107 and Glu136. Among these residues, Arg38, Ser39 and Lys42 were crucial for binding to NADP (Figs. 1B and 4C). Arg38 is well known as a crucial residue for specificity of the enzyme for NADP [17]. The guanidinium group of Arg38 established a stable π -cation interaction with the adenine ring of NADP, and the π-cation interaction and hydrogen bonds that formed between Arg38 and NADP played an important role in the stable cofactor binding of
A structural comparison between the docking simulation of 6PG and
Enzymatic Kinetics and Relative Activity
The enzymatic kinetic parameters for checking substrate and NADP affinity were obtained by measuring the initial velocity of
-
Table 2 . Kinetic analysis of
Cg 6PGD for 6PG/NADP.Kinetic parameters 6PG NADP 6PG/NADP cofactor k cat [min-1]KM [mM] k cat/KM [(mM min)-1]k cat [min-1]KM [mM] k cat/KM [(mM min)-1]Wild type 1139.55 ± 27.1 0.34084 ± 0.03 3343.358 1027.35 ± 16.9 0.16276 ± 0.0095 6312.055
-
Fig. 5. Enzymatic kinetics of
Cg 6PGD. (A) Kinetic analysis ofCg 6PGD. The reaction velocity was plotted vs. the substrate (6PG) concentration (left) and co-factor (NADP) concentration (right) based on the Michaelis-Menten equation. The experiments were performed in duplicate and the standard deviation is indicated by the error bar. Various concentrations of 6PG (0.1~5 mM) and NADP (0.01~2 mM) were used. (B) Conservation analysis of reisudes associated with NADP-binding. (C) Relative activity ofCg 6PGD. The activity value of the mutants is expressed with the wild-type form set at 100%. The green and yellow graphs present the relative activities of the NADP-binding residue and 6PG-binding residue, respectively.
A conservation analysis was performed using WebLogo to confirm the conservation of the NADP binding residue. Among the residues that were involved in binding of NADP, Ser39, Lys42, and Gln80 were not conserved in 705 homologous sequences (Fig. 5B). To check the effects of residues regarding NADPH activity, the relative activity is evaluated (Fig. 5C). In the case of Ser39, S39T showed little activity, and S39H showed a 22% activity decrease were detected compared with the wild-type (WT) form. The analysis of the structure of
In summary, we determined the crystal structures of the apo and complex forms of
Acknowledgments
This work was supported by the Cooperative Research Program for Agricultural Science & Technology Development (Project No. PJ01492602), Rural Development Administration, Republic of Korea. And this work is further supported by the Development of next-generation biorefinery platform technologies for leading bio-based chemicals industry project (2022M3J5A1056072) and by Development of platform technologies of microbial cell factories for the next-generation biorefineries project (2022M3J5A1056117) from National Research Foundation supported by the Korean Ministry of Science and ICT.
Author Contributions
H Yu: Methodology, Investigation, Experiments and Writing Original Draft, J Hong, J Seok, Y-B seo, I-K Kim: Investigation, K-J Kim: Conceptualization, Project Administration, Writing Review and Editing, Supervision, and Funding Acquisition.
References
- Kalinowski J, Bathe B, Bartels D, Bischoff N, Bott M, Burkovski A,
et al . 2003. The completeCorynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitamins.J. Biotechnol. 104 : 5-25. - Becker J, Giesselmann G, Hoffmann SL, Wittmann C. 2018.
Corynebacterium glutamicum for sustainable bioproduction: from metabolic physiology to systems metabolic engineering.Adv. Biochem. Eng. Biotechnol. 162 : 217-263. - Lee JY, Na YA, Kim E, Lee HS, Kim P. 2016. The Actinobacterium
Corynebacterium glutamicum , an industrial workhorse.J. Microbiol. Biotechnol. 26 : 807-822. - Eikmanns BJ, Eggeling L, Sahm H. 1993. Molecular aspects of lysine, threonine, and isoleucine biosynthesis in
Corynebacterium glutamicum .Antonie Van Leeuwenhoek. 64 : 145-163. - Baumgart M, Unthan S, Ruckert C, Sivalingam J, Grunberger A, Kalinowski J,
et al . 2013. Construction of a prophage-free variant ofCorynebacterium glutamicum ATCC 13032 for use as a platform strain for basic research and industrial biotechnology.Appl. Environ. Microbiol. 79 : 6006-6015. - Xu JZ, Yang HK, Zhang WG. 2018. NADPH metabolism: a survey of its theoretical characteristics and manipulation strategies in amino acid biosynthesis.
Crit. Rev. Biotechnol. 38 : 1061-1076. - Takeno S, Hori K, Ohtani S, Mimura A, Mitsuhashi S, Ikeda M. 2016. l-Lysine production independent of the oxidative pentose phosphate pathway by
Corynebacterium glutamicum with theStreptococcus mutans gapN gene.Metab. Eng. 37 : 1-10. - Sheng Q, Wu XY, Xu X, Tan X, Li Z, Zhang B. 2021. Production of l-glutamate family amino acids in
Corynebacterium glutamicum : physiological mechanism, genetic modulation, and prospects.Synth. Syst. Biotechnol. 6 : 302-325. - Ma YC, Ma Q, Cui Y, Du LH, Xie XX, Chen N. 2019. Transcriptomic and metabolomics analyses reveal metabolic characteristics of L-leucine- and L-valine-producing
Corynebacterium glutamicum mutants.Ann. Microbiol. 69 : 457-468. - Ma WJ, Wang JL, Li Y, Hu XQ, Shi F, Wang XY. 2016. Enhancing pentose phosphate pathway in
Corynebacterium glutamicum to improve L-isoleucine production.Biotechnol. Appl. Biochem. 63 : 877-885. - Pfefferle W, Mockel B, Bathe B, Marx A. 2003. Biotechnological manufacture of lysine.
Adv. Biochem. Eng. Biotechnol. 79 : 59-112. - Kimura E. 2003. Metabolic engineering of glutamate production.
Adv. Biochem. Eng. Biotechnol. 79 : 37-57. - Ikeda M. 2003. Amino acid production processes.
Adv. Biochem. Eng. Biotechnol. 79 : 1-35. - Schnarrenberger C, Flechner A, Martin W. 1995. Enzymatic evidence for a complete oxidative pentose phosphate pathway in chloroplasts and an incomplete pathway in the cytosol of spinach leaves.
Plant Physiol. 108 : 609-614. - Xia W, Wang Z, Wang Q, Han J, Zhao C, Hong Y,
et al . 2009. Roles of NAD(+)/NADH and NADP(+)/NADPH in cell death.Curr. Pharm. Des. 15 : 12-19. - Park SH, Kim HU, Kim TY, Park JS, Kim SS, Lee SY. 2014. Metabolic engineering of
Corynebacterium glutamicum for L-arginine production.Nat. Commun. 5 : 4618. - Chen YY, Ko TP, Chen WH, Lo LP, Lin CH, Wang AH. 2010. Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from
Escherichia coli andKlebsiella pneumoniae : implications for enzyme mechanism.J. Struct. Biol. 169 : 25-35. - Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou L,
et al . 2015. 6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.Nat. Cell Biol. 17 : 1484-1496. - Ruda GF, Alibu VP, Mitsos C, Bidet O, Kaiser M, Brun R,
et al . 2007. Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.ChemMedChem. 2 : 1169-1180. - Hanau S, Rinaldi E, Dallocchio F, Gilbert IH, Dardonville C, Adams MJ,
et al . 2004. 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.Curr. Med. Chem. 11 : 2639-2650. - Park S-Y, Ha S-C, Kim Y-G. 2017. The protein crystallography beamlines at the pohang light source II.
Biodesign. 5 : 30-34. - Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 276 : 307-326. - Matthews BW. 1968. Solvent content of protein crystals.
J. Mol. Biol. 33 : 491-497. - Collaborative Computational Project N. 1994. The CCP4 suite: programs for protein crystallography.
Acta Crystallogr. D Biol. Crystallogr. 50 : 760-763. - Vagin A, Teplyakov A. 2010. Molecular replacement with MOLREP.
Acta Crystallogr. D Biol. Crystallogr. 66 : 22-25. - Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol. Crystallogr. 60 : 2126-2132. - Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA,
et al . 2011. REFMAC5 for the refinement of macromolecular crystal structures.Acta Crystallogr. D Biol. Crystallogr. 67 : 355-367. - Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method.
Acta Crystallogr. D Biol Crystallogr. 53 : 240-255. - Sievers F, Higgins DG. 2014. Clustal omega.
Curr. Protoc. Bioinformatics 48 : 3 13 11-13 13 16. - Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator.
Genome Res. 14 : 1188-1190. - Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
J. Comput. Chem. 31 : 455-461. - Cameron S, Martini VP, Iulek J, Hunter WN. 2009.
Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate.Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65 : 450-454. - Rippa M, Giovannini PP, Barrett MP, Dallocchio F, Hanau S. 1998. 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.
Biochim. Biophys. Acta. 1429 : 83-92. - Sundaramoorthy R, Iulek J, Barrett MP, Bidet O, Ruda GF, Gilbert IH,
et al . 2007. Crystal structures of a bacterial 6-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates.FEBS J. 274 : 275-286. - Adams MJ, Ellis GH, Gover S, Naylor CE, Phillips C. 1994. Crystallographic study of coenzyme, coenzyme analog and substrate-Binding in 6-phosphogluconate dehydrogenase - implications for Nadp specificity and the enzyme mechanism (Vol. 2, Pg 651, 1994).
Structure 2 : 784-784. - Lei Z, Chooback L, Cook PF. 1999. Lysine 183 is the general base in the 6-phosphogluconate dehydrogenase-catalyzed reaction.
Biochemistry 38 : 11231-11238. - Li L, Dworkowski FSN, Cook PF. 2006. Importance in catalysis of the 6-phosphate-binding site of 6-phosphogluconate in sheep liver 6-phosphogluconate dehydrogenase.
J. Biol. Chem. 281 : 25568-25576. - Lou D, Wang B, Tan J, Zhu L, Cen X, Ji Q,
et al . 2016. The three-dimensional structure of Clostridium absonum 7alpha-hydroxysteroid dehydrogenase: new insights into the conserved arginines for NADP(H) recognition.Sci. Rep. 6 : 22885. - Dambe TR, Kuhn AM, Brossette T, Giffhorn F, Scheidig AJ. 2006. Crystal structure of NADP(H)-dependent 1,5-anhydro-Dfructose reductase from
Sinorhizobium morelense at 2.2 A resolution: construction of a NADH-accepting mutant and its application in rare sugar synthesis.Biochemistry 45 : 10030-10042. - Kitatani T, Nakamura Y, Wada K, Kinoshita T, Tamoi M, Shigeoka S,
et al . 2006. Structure of NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Synechococcus PCC7942 complexed with NADP.Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62 : 315-319. - Haeussler K, Fritz-Wolf K, Reichmann M, Rahlfs S, Becker K. 2018. Characterization of
Plasmodium falciparum 6-phosphogluconate dehydrogenase as an antimalarial drug target.J. Mol. Biol. 430 : 4049-4067. - Hua YH, Wu CY, Sargsyan K, Lim C. 2014. Sequence-motif detection of NAD(P)-binding proteins: discovery of a unique antibacterial drug target.
Sci. Rep. 4 : 6471.
Related articles in JMB
Article
Research article
J. Microbiol. Biotechnol. 2023; 33(10): 1361-1369
Published online October 28, 2023 https://doi.org/10.4014/jmb.2305.05002
Copyright © The Korean Society for Microbiology and Biotechnology.
Crystal Structures of 6-Phosphogluconate Dehydrogenase from Corynebacterium glutamicum
Hyeonjeong Yu1, Jiyeon Hong2, Jihye Seok1, Young-Bae Seu1,2, Il-Kwon Kim2, and Kyung-Jin Kim1,2*
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea
2KNU Institute for Microorganisms, Kyungpook National University, Daegu 41566, Republic of Korea
Correspondence to:Kyung-Jin Kim, kkim@knu.ac.kr
Abstract
Corynebacterium glutamicum (C. glutamicum) has been considered a very important and meaningful industrial microorganism for the production of amino acids worldwide. To produce amino acids, cells require nicotinamide adenine dinucleotide phosphate (NADPH), which is a biological reducing agent. The pentose phosphate pathway (PPP) can supply NADPH in cells via the 6-phosphogluconate dehydrogenase (6PGD) enzyme, which is an oxidoreductase that converts 6-phosphogluconate (6PG) to ribulose 5-phosphate (Ru5P), to produce NADPH. In this study, we identified the crystal structure of 6PGD_apo and 6PGD_NADP from C. glutamicum ATCC 13032 (Cg6PGD) and reported our biological research based on this structure. We identified the substrate binding site and co-factor binding site of Cg6PGD, which are crucial for understanding this enzyme. Based on the findings of our research, Cg6PGD is expected to be used as a NADPH resource in the food industry and as a drug target in the pharmaceutical industry.
Keywords: 6-Phosphogluconate dehydrogenase, Corynebacterium glutamicum, crystal structure, 6-phosphogluconate, nicotinamide adenine dinucleotide phosphate
Introduction
The PPP, which is the essential pathway in cellular metabolism, provides a precursor for nucleotide or amino acid synthesis and protects cells against oxidative stress. The PPP can be divided into two phases : the oxidative phase (OPPP) and the non-oxidative phase (NOPPP). During the oxidative phase, NADPH is produced from glucose using the reducing power of glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGD). These two isoenzymes play an important role in this pathway in terms of the production of NADPH, which is an essential co-factor to the survival of cells and a biological reducing agent that is used in the synthesis of fatty acids and cholesterol [14]. Moreover, many studies have indicated that NADPH is a key factor in cellular antioxidation systems and oxidative stress [15]. However, cells contain more NAD than NADP. Therefore, a suitable intracellular NADPH level is important for maintaining the redox balance in cells [16]. To reduce this imbalance of energy-carrying molecules in cells, many researchers have attempted to replace NADP-dependent enzyme with NAD-dependent enzyme. For this reason, G6PDH and 6PGD, which can produce NADPH, are important. These enzymes react with NADP, rather than NAD, thus easily offering NADPH in cells.
Furthermore, 6PGD, which catalyzes the conversion of 6-phosphogluconate (6PG) to ribulose 5-phosphate (Ru5P) using NADP in the third step of PPP, to produce NADPH (Fig. 1A) [17], is well known as a drug target in cancer and infection. Studies on the control of 6PGD revealed that this causes a decrease in lipogenesis and RNA biosysnthesis and an increase in ROS levels, consequently hindering the growth of cancer cells [18] . Moreover, 6PGD plays an important role in the metabolic system, but also acts as a potential drug target for African trypanosomes [19, 20]. The structures of the 6PGD-based amino acid sequences from
-
Figure 1. Reaction and sequence alignment of
Cg 6PGD. (A) Enzymatic reaction of 6-phospho gluconate dehydrogenase. NADPH and CO2 are produced from this reaction. (B) Amino acid sequence alignment ofCg 6PGD with other 6PGD structures. The secondary structural elements are drawn based on the structure ofCg 6PGD and labeled. Residues that were involved in catalytic activity, substate-binding, and NADP-binding are presented using differently colored triangles, respectively.
The present research focused on the 6PGD from
Materials and Methods
Expression and Purification
The
Crystallization
After the purification of the
Each experiment consisted of mixing 1.0 ul of protein solution (41.25 mg ml–1 in 40 mM Tris-HCl, pH 8.0) with 1.0 ml of reservoir solution and equilibrating the drop against 50 ul of reservoir solution. The crystals of
Data Collection and Structure Determination
The best quality
-
Table 1 . Data collection and refinement statistics of
Cg 6PGD apo and complex form..Cg 6PGD_apoCg 6PGD_NADPData collection Space group P 21 21 21 P 21 21 21 Cell dimensions a, b, c (Å)63.90 120.30 152.60 64.00 119.47 153.45 α, β, γ () 90.00 90.00 90.00 90.00, 90.00, 90.00 Resolution (Å) 50.00-2.44 50.00-1.93 R sym orR merge12.1 (36.9) 6.5 (33.8) CC1/2 0.978 (0.773) 0.992 (0.93) I / σ (I) 15.9 (3.18) 35.667 (6.865) Completeness (%) 94.9 (92.4) 99.0 (97.4) Redundancy 3.2 (2.5) 5.5 (5.5) Refinement Resolution (Å) 33.99-2.41 33.84-1.90 No. reflections 41803 87822 R work /R free19.951 / 26.708 16.408 / 20.217 No. atoms 7314 8011 Protein 7238 7218 Ligand/ion 0 143 Water 76 650 B -factors39.794 22.082 Protein 42.582 22.903 Ligand/ion 0 44.127 Water 35.828 30.075 R.m.s. deviations Bond lengths (Å) 0.008 0.011 Bond angles (°) 1.615 1.643 PDB ID 8I4N 8I4Q
Analytical Size-Exclusion Chromatography
To determine the oligomeric status of
Amino Acid Sequence Analysis of Substrate Binding Site
The amino acid sequence analysis was performed using a position-specific iterated basic local alignment search tool (PSI-BLAST). For this, 705
Molecular Docking Simulation
A simulation of the molecular docking of 6PG to the
The grid box size for
Enzymatic Activity Assay
The Enzymatic activity of
Results and Discussion
Overall Structure of Cg 6PGD
We determined that the crystal structures of
-
Figure 2. Overall structure of
Cg 6PGD. (A) Dimeric structure ofCg 6PGD. The dimeric structure is shown as a cartoon model, and the two chains are distinguished with different colors : green and magenta, respectively. NADP is presented as a gray-colored sphere model. (B) Size-exclusion chromatography ofCg 6PGD. a is a void peak, b is ferritin (440 kDa), c is aldolase (158 kDa), d is ovalbumin (44 kDa) and e is ribonuclease (13.7 kDa).Cg 6PGD is eluted as a dimer. (C) Domain classification ofCg 6PGD using a cartoon model of the monomer. The N-term domain is indicated in blue, the CD is indicated in red, and the Cterm domain is indicated in yellow.
The monomeric structure of
Substrate-Binding Site and Catalytic Residues
The substrate-binding mode was predicted via the alignment of our structure with the
-
Figure 3. Substrate(6PG)-binding model of
Cg 6PGD. (A) Structure comparison betweenOa 6PGD_apo,Oa 6PGD_6PG andCg 6PGD_apo. All structures are presented as cartoon diagrams. The structures are depicted in gray (Oa 6PGD_apo), purple (Oa 6PGD_6PG) and cyan (Cg 6PGD). (B) Docking simulation ofCg 6PGD with 6PG. Hydrogen bonds between the residues and 6PG are expressed, with the exception of water-meditated hydrogen bonds. 6PG is presented as a magenta-colored stick model, and the substrate-binding residue is presented as a cyan-colored stick model. All residues are labeled. (C) Domains associated with the binding of 6PG. (D) Catalytic residues ofCg 6PGD andOa 6PGD.Cg 6PGD is presented as a cyan-colored cartoon model, andOa 6PGD is presented as a green-colored cartoon model. The catalytic residues are presented using sticks and labeled.
Docking simulations of the substrate were also performed to predict the substrate-binding mode. The 6PG molecule fitted the substrate-binding cavity well, which was predicted based on other similar structure (Fig. 3B). In the substrate-binding pocket, the N-term domain, CD, C-term domain were involved in the binding of substrate. The phosphate of 6PG interacted with Tyr195, Lys260 and Arg287 in the CD; and with Arg446 in the C-term domain of another chain (Figs. 3B and 3C).
The catalytic residues of 6PGD are well known,
NADP-Binding Site
To characterize the conformational change between
-
Figure 4. Co-factor (NADP)-binding model of
Cg 6PGD. (A) Electrostatic potential surface of theCg 6PGD_apo (left) andCg 6PGD_NADP (right) forms. NADP molecules are shown as gray-colored stick models. (B) Conformational changes inCg 6PGD_NADP. NADP is presented as a sphere model. The difference in loop distance is labeled. (C) Co-factor (NADP)- binding model ofCg 6PGD. The structure ofCg 6PGD is shown as a cartoon diagram, and the residues that bind to NADP are presented as stick models and labeled. (D) Pyrophosphate of the NADP-binding form.
A NADP-binding site was observed in the N-term domain. The NADP-binding site was constructed by Ala16, Met18, Asn37, Arg38, Ser39, Lys42, Val79, Gln80, Asn107 and Glu136. Among these residues, Arg38, Ser39 and Lys42 were crucial for binding to NADP (Figs. 1B and 4C). Arg38 is well known as a crucial residue for specificity of the enzyme for NADP [17]. The guanidinium group of Arg38 established a stable π -cation interaction with the adenine ring of NADP, and the π-cation interaction and hydrogen bonds that formed between Arg38 and NADP played an important role in the stable cofactor binding of
A structural comparison between the docking simulation of 6PG and
Enzymatic Kinetics and Relative Activity
The enzymatic kinetic parameters for checking substrate and NADP affinity were obtained by measuring the initial velocity of
-
Table 2 . Kinetic analysis of
Cg 6PGD for 6PG/NADP..Kinetic parameters 6PG NADP 6PG/NADP cofactor k cat [min-1]KM [mM] k cat/KM [(mM min)-1]k cat [min-1]KM [mM] k cat/KM [(mM min)-1]Wild type 1139.55 ± 27.1 0.34084 ± 0.03 3343.358 1027.35 ± 16.9 0.16276 ± 0.0095 6312.055
-
Figure 5. Enzymatic kinetics of
Cg 6PGD. (A) Kinetic analysis ofCg 6PGD. The reaction velocity was plotted vs. the substrate (6PG) concentration (left) and co-factor (NADP) concentration (right) based on the Michaelis-Menten equation. The experiments were performed in duplicate and the standard deviation is indicated by the error bar. Various concentrations of 6PG (0.1~5 mM) and NADP (0.01~2 mM) were used. (B) Conservation analysis of reisudes associated with NADP-binding. (C) Relative activity ofCg 6PGD. The activity value of the mutants is expressed with the wild-type form set at 100%. The green and yellow graphs present the relative activities of the NADP-binding residue and 6PG-binding residue, respectively.
A conservation analysis was performed using WebLogo to confirm the conservation of the NADP binding residue. Among the residues that were involved in binding of NADP, Ser39, Lys42, and Gln80 were not conserved in 705 homologous sequences (Fig. 5B). To check the effects of residues regarding NADPH activity, the relative activity is evaluated (Fig. 5C). In the case of Ser39, S39T showed little activity, and S39H showed a 22% activity decrease were detected compared with the wild-type (WT) form. The analysis of the structure of
In summary, we determined the crystal structures of the apo and complex forms of
Acknowledgments
This work was supported by the Cooperative Research Program for Agricultural Science & Technology Development (Project No. PJ01492602), Rural Development Administration, Republic of Korea. And this work is further supported by the Development of next-generation biorefinery platform technologies for leading bio-based chemicals industry project (2022M3J5A1056072) and by Development of platform technologies of microbial cell factories for the next-generation biorefineries project (2022M3J5A1056117) from National Research Foundation supported by the Korean Ministry of Science and ICT.
Author Contributions
H Yu: Methodology, Investigation, Experiments and Writing Original Draft, J Hong, J Seok, Y-B seo, I-K Kim: Investigation, K-J Kim: Conceptualization, Project Administration, Writing Review and Editing, Supervision, and Funding Acquisition.
Fig 1.
Fig 2.
Fig 3.
Fig 4.
Fig 5.
-
Table 1 . Data collection and refinement statistics of
Cg 6PGD apo and complex form..Cg 6PGD_apoCg 6PGD_NADPData collection Space group P 21 21 21 P 21 21 21 Cell dimensions a, b, c (Å)63.90 120.30 152.60 64.00 119.47 153.45 α, β, γ () 90.00 90.00 90.00 90.00, 90.00, 90.00 Resolution (Å) 50.00-2.44 50.00-1.93 R sym orR merge12.1 (36.9) 6.5 (33.8) CC1/2 0.978 (0.773) 0.992 (0.93) I / σ (I) 15.9 (3.18) 35.667 (6.865) Completeness (%) 94.9 (92.4) 99.0 (97.4) Redundancy 3.2 (2.5) 5.5 (5.5) Refinement Resolution (Å) 33.99-2.41 33.84-1.90 No. reflections 41803 87822 R work /R free19.951 / 26.708 16.408 / 20.217 No. atoms 7314 8011 Protein 7238 7218 Ligand/ion 0 143 Water 76 650 B -factors39.794 22.082 Protein 42.582 22.903 Ligand/ion 0 44.127 Water 35.828 30.075 R.m.s. deviations Bond lengths (Å) 0.008 0.011 Bond angles (°) 1.615 1.643 PDB ID 8I4N 8I4Q
-
Table 2 . Kinetic analysis of
Cg 6PGD for 6PG/NADP..Kinetic parameters 6PG NADP 6PG/NADP cofactor k cat [min-1]KM [mM] k cat/KM [(mM min)-1]k cat [min-1]KM [mM] k cat/KM [(mM min)-1]Wild type 1139.55 ± 27.1 0.34084 ± 0.03 3343.358 1027.35 ± 16.9 0.16276 ± 0.0095 6312.055
References
- Kalinowski J, Bathe B, Bartels D, Bischoff N, Bott M, Burkovski A,
et al . 2003. The completeCorynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitamins.J. Biotechnol. 104 : 5-25. - Becker J, Giesselmann G, Hoffmann SL, Wittmann C. 2018.
Corynebacterium glutamicum for sustainable bioproduction: from metabolic physiology to systems metabolic engineering.Adv. Biochem. Eng. Biotechnol. 162 : 217-263. - Lee JY, Na YA, Kim E, Lee HS, Kim P. 2016. The Actinobacterium
Corynebacterium glutamicum , an industrial workhorse.J. Microbiol. Biotechnol. 26 : 807-822. - Eikmanns BJ, Eggeling L, Sahm H. 1993. Molecular aspects of lysine, threonine, and isoleucine biosynthesis in
Corynebacterium glutamicum .Antonie Van Leeuwenhoek. 64 : 145-163. - Baumgart M, Unthan S, Ruckert C, Sivalingam J, Grunberger A, Kalinowski J,
et al . 2013. Construction of a prophage-free variant ofCorynebacterium glutamicum ATCC 13032 for use as a platform strain for basic research and industrial biotechnology.Appl. Environ. Microbiol. 79 : 6006-6015. - Xu JZ, Yang HK, Zhang WG. 2018. NADPH metabolism: a survey of its theoretical characteristics and manipulation strategies in amino acid biosynthesis.
Crit. Rev. Biotechnol. 38 : 1061-1076. - Takeno S, Hori K, Ohtani S, Mimura A, Mitsuhashi S, Ikeda M. 2016. l-Lysine production independent of the oxidative pentose phosphate pathway by
Corynebacterium glutamicum with theStreptococcus mutans gapN gene.Metab. Eng. 37 : 1-10. - Sheng Q, Wu XY, Xu X, Tan X, Li Z, Zhang B. 2021. Production of l-glutamate family amino acids in
Corynebacterium glutamicum : physiological mechanism, genetic modulation, and prospects.Synth. Syst. Biotechnol. 6 : 302-325. - Ma YC, Ma Q, Cui Y, Du LH, Xie XX, Chen N. 2019. Transcriptomic and metabolomics analyses reveal metabolic characteristics of L-leucine- and L-valine-producing
Corynebacterium glutamicum mutants.Ann. Microbiol. 69 : 457-468. - Ma WJ, Wang JL, Li Y, Hu XQ, Shi F, Wang XY. 2016. Enhancing pentose phosphate pathway in
Corynebacterium glutamicum to improve L-isoleucine production.Biotechnol. Appl. Biochem. 63 : 877-885. - Pfefferle W, Mockel B, Bathe B, Marx A. 2003. Biotechnological manufacture of lysine.
Adv. Biochem. Eng. Biotechnol. 79 : 59-112. - Kimura E. 2003. Metabolic engineering of glutamate production.
Adv. Biochem. Eng. Biotechnol. 79 : 37-57. - Ikeda M. 2003. Amino acid production processes.
Adv. Biochem. Eng. Biotechnol. 79 : 1-35. - Schnarrenberger C, Flechner A, Martin W. 1995. Enzymatic evidence for a complete oxidative pentose phosphate pathway in chloroplasts and an incomplete pathway in the cytosol of spinach leaves.
Plant Physiol. 108 : 609-614. - Xia W, Wang Z, Wang Q, Han J, Zhao C, Hong Y,
et al . 2009. Roles of NAD(+)/NADH and NADP(+)/NADPH in cell death.Curr. Pharm. Des. 15 : 12-19. - Park SH, Kim HU, Kim TY, Park JS, Kim SS, Lee SY. 2014. Metabolic engineering of
Corynebacterium glutamicum for L-arginine production.Nat. Commun. 5 : 4618. - Chen YY, Ko TP, Chen WH, Lo LP, Lin CH, Wang AH. 2010. Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from
Escherichia coli andKlebsiella pneumoniae : implications for enzyme mechanism.J. Struct. Biol. 169 : 25-35. - Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou L,
et al . 2015. 6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.Nat. Cell Biol. 17 : 1484-1496. - Ruda GF, Alibu VP, Mitsos C, Bidet O, Kaiser M, Brun R,
et al . 2007. Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.ChemMedChem. 2 : 1169-1180. - Hanau S, Rinaldi E, Dallocchio F, Gilbert IH, Dardonville C, Adams MJ,
et al . 2004. 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.Curr. Med. Chem. 11 : 2639-2650. - Park S-Y, Ha S-C, Kim Y-G. 2017. The protein crystallography beamlines at the pohang light source II.
Biodesign. 5 : 30-34. - Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 276 : 307-326. - Matthews BW. 1968. Solvent content of protein crystals.
J. Mol. Biol. 33 : 491-497. - Collaborative Computational Project N. 1994. The CCP4 suite: programs for protein crystallography.
Acta Crystallogr. D Biol. Crystallogr. 50 : 760-763. - Vagin A, Teplyakov A. 2010. Molecular replacement with MOLREP.
Acta Crystallogr. D Biol. Crystallogr. 66 : 22-25. - Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol. Crystallogr. 60 : 2126-2132. - Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA,
et al . 2011. REFMAC5 for the refinement of macromolecular crystal structures.Acta Crystallogr. D Biol. Crystallogr. 67 : 355-367. - Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method.
Acta Crystallogr. D Biol Crystallogr. 53 : 240-255. - Sievers F, Higgins DG. 2014. Clustal omega.
Curr. Protoc. Bioinformatics 48 : 3 13 11-13 13 16. - Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator.
Genome Res. 14 : 1188-1190. - Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
J. Comput. Chem. 31 : 455-461. - Cameron S, Martini VP, Iulek J, Hunter WN. 2009.
Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate.Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65 : 450-454. - Rippa M, Giovannini PP, Barrett MP, Dallocchio F, Hanau S. 1998. 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.
Biochim. Biophys. Acta. 1429 : 83-92. - Sundaramoorthy R, Iulek J, Barrett MP, Bidet O, Ruda GF, Gilbert IH,
et al . 2007. Crystal structures of a bacterial 6-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates.FEBS J. 274 : 275-286. - Adams MJ, Ellis GH, Gover S, Naylor CE, Phillips C. 1994. Crystallographic study of coenzyme, coenzyme analog and substrate-Binding in 6-phosphogluconate dehydrogenase - implications for Nadp specificity and the enzyme mechanism (Vol. 2, Pg 651, 1994).
Structure 2 : 784-784. - Lei Z, Chooback L, Cook PF. 1999. Lysine 183 is the general base in the 6-phosphogluconate dehydrogenase-catalyzed reaction.
Biochemistry 38 : 11231-11238. - Li L, Dworkowski FSN, Cook PF. 2006. Importance in catalysis of the 6-phosphate-binding site of 6-phosphogluconate in sheep liver 6-phosphogluconate dehydrogenase.
J. Biol. Chem. 281 : 25568-25576. - Lou D, Wang B, Tan J, Zhu L, Cen X, Ji Q,
et al . 2016. The three-dimensional structure of Clostridium absonum 7alpha-hydroxysteroid dehydrogenase: new insights into the conserved arginines for NADP(H) recognition.Sci. Rep. 6 : 22885. - Dambe TR, Kuhn AM, Brossette T, Giffhorn F, Scheidig AJ. 2006. Crystal structure of NADP(H)-dependent 1,5-anhydro-Dfructose reductase from
Sinorhizobium morelense at 2.2 A resolution: construction of a NADH-accepting mutant and its application in rare sugar synthesis.Biochemistry 45 : 10030-10042. - Kitatani T, Nakamura Y, Wada K, Kinoshita T, Tamoi M, Shigeoka S,
et al . 2006. Structure of NADP-dependent glyceraldehyde-3-phosphate dehydrogenase from Synechococcus PCC7942 complexed with NADP.Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62 : 315-319. - Haeussler K, Fritz-Wolf K, Reichmann M, Rahlfs S, Becker K. 2018. Characterization of
Plasmodium falciparum 6-phosphogluconate dehydrogenase as an antimalarial drug target.J. Mol. Biol. 430 : 4049-4067. - Hua YH, Wu CY, Sargsyan K, Lim C. 2014. Sequence-motif detection of NAD(P)-binding proteins: discovery of a unique antibacterial drug target.
Sci. Rep. 4 : 6471.